Skip to main content
Hualan Biological Engineering Inc. logo

Hualan Biological Engineering Inc. — Investor Relations & Filings

Ticker · 002007 ISIN · CNE000001JN8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2022-03-29 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002007

About Hualan Biological Engineering Inc.

https://www.hualanbio.com

Hualan Biological Engineering Inc. is a biopharmaceutical enterprise specializing in the research, development, production, and commercialization of blood products and vaccines. The company’s portfolio is divided into two primary segments: plasma-derived therapeutics and viral vaccines. Key blood products include human albumin, intravenous immunoglobulin (IVIG), human coagulation factor VIII, and prothrombin complex. In the vaccine sector, the company produces seasonal influenza vaccines, including quadrivalent formulations, as well as hepatitis B and rabies vaccines. Hualan Biological Engineering operates advanced manufacturing facilities and plasma collection centers, focusing on high-quality standards and technological innovation in recombinant protein drugs and monoclonal antibodies to address critical medical needs in immunology, hematology, and infectious disease prevention.

Recent filings

Filing Released Lang Actions
关于董事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of the new board of directors for the company 华兰生物工程股份有限公司. It details the nomination and qualifications of candidates for the eighth board, including independent and non-independent directors, and references compliance with relevant laws and regulations. There is no financial data or report content, but rather a formal disclosure about board changes. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length is 4236 characters, which is consistent with an announcement rather than a full report.
2022-03-29 Chinese
华兰生物工程股份有限公司股东大会议事规则
Governance Information Classification · 100% confidence The document is titled as the "Rules of Procedure for the Shareholders' General Meeting" of a company. It extensively details the organization, rights, procedures, and regulations governing the shareholders' meetings, including the convening, proposals, voting, and record-keeping. It does not contain financial statements, earnings data, or audit information. Instead, it is a governance document outlining internal rules and procedures related to shareholder meetings. Therefore, it fits best under Governance Information (CGR). The document length and content confirm it is not a brief announcement or a report publication notice, but a full governance rules document.
2022-03-29 Chinese
关于使用自有资金进行投资理财的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by a company regarding the use of its own funds for investment and financial management. It details the investment purpose, amount, objects, approval procedures, impact on the company, risk control measures, and independent directors' opinions. The document is relatively short (1368 characters) and does not contain financial statements or detailed financial data. It is an announcement about a capital use decision rather than a financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP).
2022-03-29 Chinese
独立董事提名人声明（三）
Board/Management Information Classification · 95% confidence The document is a formal public statement from the board of directors nominating an independent director candidate for the company's board. It details the nominee's qualifications, compliance with relevant laws and regulations, and independence criteria. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management information, specifically the nomination of a board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length is about 4972 characters, which is consistent with a detailed nomination statement rather than a brief announcement or report publication.
2022-03-29 Chinese
独立董事提名人声明（一）
Board/Management Information Classification · 95% confidence The document is a public statement from the board of directors nominating an independent director candidate for the company's board. It details the nominee's qualifications, compliance with various regulatory requirements, and declarations regarding independence and eligibility. There is no financial data, no discussion of financial results, no mention of shareholder voting results, or any other report type. This document is an announcement related to board/management changes, specifically the nomination of a board member. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is about 4969 characters, which is consistent with a detailed announcement rather than a full report or a brief notice.
2022-03-29 Chinese
独立董事候选人声明（刘万丽）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of a company, confirming compliance with various legal and regulatory requirements for the position. It is a statement of qualifications and independence, not a financial report, meeting materials, or announcement of voting results. It does not contain financial data, management discussion, or any report publication. It is a regulatory compliance statement related to board/management information but specifically about the candidate's qualifications and independence. This fits best under Board/Management Information (MANG), which covers announcements related to changes or appointments in the company's board or senior management.
2022-03-29 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.